Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Cash from Financing Activities: 2020-2025

Historic Cash from Financing Activities for iSpecimen (ISPC) over the last 2 years, with Sep 2025 value amounting to $5.2 million.

  • iSpecimen's Cash from Financing Activities rose 508.11% to $5.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.2 million, marking a year-over-year increase of 444.81%. This contributed to the annual value of $5.8 million for FY2024, which is 8108.47% up from last year.
  • According to the latest figures from Q3 2025, iSpecimen's Cash from Financing Activities is $5.2 million, which was up 38.63% from $3.8 million recorded in Q4 2024.
  • In the past 5 years, iSpecimen's Cash from Financing Activities ranged from a high of $19.6 million in Q4 2021 and a low of -$3.5 million during Q4 2022.
  • Moreover, its 3-year median value for Cash from Financing Activities was $859,980 (2024), whereas its average is $1.6 million.
  • Within the past 5 years, the most significant YoY rise in iSpecimen's Cash from Financing Activities was 41,304.50% (2024), while the steepest drop was 275.47% (2024).
  • Quarterly analysis of 5 years shows iSpecimen's Cash from Financing Activities stood at $19.6 million in 2021, then slumped by 117.88% to -$3.5 million in 2022, then slumped by 60.96% to $3,153 in 2023, then spiked by 41,304.50% to $3.8 million in 2024, then spiked by 508.11% to $5.2 million in 2025.
  • Its Cash from Financing Activities was $5.2 million in Q3 2025, compared to $3.8 million in Q4 2024 and $859,980 in Q3 2024.